Get the Stockscreener App
3.675
11.70%
0.385
Pre-market:
3.74
0.065
+1.77%
Absci Corp stock is traded at $3.675, with a volume of 9.87M.
It is up +11.70% in the last 24 hours and down -6.73% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$3.29
Open:
$3.3
24h Volume:
9.87M
Relative Volume:
1.86
Market Cap:
$552.62M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-3.9516
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
+18.93%
1M Performance:
-6.73%
6M Performance:
+28.95%
1Y Performance:
+18.93%
1-Day Range:
$3.29
$3.96
1-Week Range:
$2.985
$3.96
52-Week Range:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.675 | 494.72M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-25 | Initiated | JP Morgan | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Assessing Absci (ABSI) Valuation After First Volunteers Dosed in ABS-201 HeadLINE Trial - simplywall.st
Absci Corp. Strives for New Horizons Amid Financial Adjustments - timothysykes.com
Absci announces first participants dosed in Phase 1/2a HEADLINE trial - TipRanks
Absci (ABSI): Assessing Valuation as AI‑Designed Hair Loss Drug Enters First Phase 1/2a Trial - Yahoo Finance
Absci doses first volunteers in phase 1/2a trial of hair loss antibody - Investing.com Australia
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial - TradingView
Absci (Nasdaq: ABSI) doses first volunteers in Phase 1/2a ABS-201 hair loss trial - Stock Titan
Will Absci Corporation stock deliver shareholder valueJuly 2025 Opening Moves & AI Optimized Trade Strategies - Newser
Absci stock price target raised to $9 from $8 at Jones Trading By Investing.com - Investing.com South Africa
Absci stock price target raised to $9 from $8 at Jones Trading - Investing.com Canada
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛
Absci Corp. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Will Absci Corporation see short term momentumWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
How Absci Corporation stock benefits from tech adoptionJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
Can trapped investors hope for a rebound in Absci CorporationGlobal Markets & Community Shared Stock Ideas - newser.com
Can Absci Corporation stock double in next 5 yearsMarket Growth Report & Expert Approved Momentum Trade Ideas - newser.com
Will Absci Corporation stock maintain growth storyJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Absci Corp’s Earnings Call Highlights Strategic Growth - MSN
Can Absci Corporation stock deliver sustainable ROE2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Absci (ABSI) Valuation in Focus as Clinical Expansion and Partnership Efforts Gather Pace - Yahoo Finance
Can Absci Corporation stock surprise with earnings upsideJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Real time pattern detection on Absci Corporation stockPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
Absci Corporation Advances AI-Driven Therapeutics - MSN
Absci Corporation (NASDAQ:ABSI) Q3 2025 Earnings Call Transcript - Insider Monkey
Absci Stock Takes a Leap: What’s Next? - StocksToTrade
Needham & Company LLC Cuts Absci (NASDAQ:ABSI) Price Target to $7.00 - MarketBeat
Why Absci Corporation stock remains a top recommendation2025 Key Lessons & Long-Term Growth Portfolio Plans - Fundação Cultural do Pará
Is Absci’s (ABSI) Lower Per-Share Loss a Sign of Rising Efficiency or Just a Temporary Shift? - Yahoo Finance
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Is Absci Corporation stock dividend yield sustainableDollar Strength & Short-Term Trading Alerts - newser.com
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Absci reports Q3 EPS (20c), consensus (21c) - MSN
Absci expects cash to fund operations into the first half of 2028 - MSN
AbSci Corp options imply 13.2% move in share price post-earnings - MSN
Absci (ABSI) Q3 2025 Earnings Call Transcript - Nasdaq
Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAbsci (NASDAQ:ABSI), Ardent Health (NYSE:ARDT) - Benzinga
Needham Maintains Buy Rating for ABSI, Lowers Price Target | ABS - GuruFocus
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Cuts Target Price to $7 - 富途牛牛
Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):